Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Moodys
Argus Health
Boehringer Ingelheim
Daiichi Sankyo
Covington
Johnson and Johnson
Citi
Cantor Fitzgerald

Generated: April 25, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: treprostinil

« Back to Dashboard

treprostinil

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
United Therap REMODULIN treprostinil INJECTABLE;IV (INFUSION), SUBCUTANEOUS 021272 NDA United Therapeutics Corporation N 66302-101-01
United Therap REMODULIN treprostinil INJECTABLE;IV (INFUSION), SUBCUTANEOUS 021272 NDA United Therapeutics Corporation N 66302-102-01
United Therap REMODULIN treprostinil INJECTABLE;IV (INFUSION), SUBCUTANEOUS 021272 NDA United Therapeutics Corporation N 66302-105-01
United Therap REMODULIN treprostinil INJECTABLE;IV (INFUSION), SUBCUTANEOUS 021272 NDA United Therapeutics Corporation N 66302-110-01
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Chubb
Cantor Fitzgerald
Baxter
Dow
QuintilesIMS
Queensland Health
AstraZeneca